GLOBAL MARIJUANA MARKET was valued at USD 17.18 Billion in the year 2017. Global Marijuana Market is further estimated to grow at a CAGR of 22.91% from 2018 to reach USD 58.90 Billion by the year 2023. North America region holds the highest market share in 2017 and also considered as the fastest growing market in the forecasted period. At a country level, developed markets like the U.S., Canada holds a substantial market share in 2017 and it is projected to grow at a gradual pace in the coming years.
Canopy Growth Corporation (Canada), Medical Marijuana, Inc. (U.S), GW Pharmaceuticals, plc (U.K), United Cannabis (U.S), Cannabis Sativa, Inc. (U.S), GreenGro Technologies (U.S), Aurora Cannabis (Canada), CannaGrow Holdings, Inc. (U.S), Cara Therapeutics (U.S), GBSciences, Inc. (U.S), Lexaria Bioscience Corp. (Canada), Aphria (Liberty Health Sciences) (Canada), are some of the key players in the Marijuana Market with Canopy Growth Corporation holding the significant market share because of its better global presence both at production and at an operational level. Rising research and development expenses to address the changing demand of end users. Similarly, growth strategies such as acquisition, merger, and expansion of the distribution network were few techniques adopted by most of the top players in the last 5 years.
Growing use of marijuana in the medical industry
The stigma of marijuana in society
Increasing demand in healthcare and pharmaceutical industry
Different government regulation in different countries
The Global Marijuana Market is segmented on the basis of product types, application, usage, and region. By Application, pain management is expected to hold the highest market share during the forecast period. On the other hand, by usage, medical usage holds the highest market and also considered as fastest growing with highest CAGR during the year 2018-2023.
Key Benefits for Stakeholders
Marijuana Manufacturers, Marijuana Associations
Research and Consulting organization, Medical Associations
By Product Type
Key Market Players
Canopy Growth Corporation
GW Pharmaceuticals, PLC
Medical Marijuana, Inc.
Cannabis Sativa, Inc.
CannaGrow Holdings, Inc.
Lexaria Bioscience Corp.
Aphria (Liberty Health Sciences)
(Another brief information of 13 companies will be provided in the report.)
Genesis Market Insights follows in-depth Research Methodology focused on reducing deviation in the collected data. GMI offers the most precise evaluations and projection for the market numbers. GMI engages following Market Engineering techniques –
Detailed customization is also available for you. Further, if the report listed above does not meet your key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
18.104.22.168. Key Data from Secondary Research
2.1.2. Primary Research
22.214.171.124. Key Data from Primary Research
126.96.36.199. Breakdowns of Primary Interviews
2.2. Market Size Estimation
2.2.1. Bottoms-Up Approach
2.2.2. Top-Down Approach
2.2.3. Annual Revenue Process
2.3. Data Triangulation
2.4. Research Assumptions
3. Executive Summary
4. Market Overview
4.7. Supply Chain/Value Chain Analysis
4.8. Patent & Standards
5. Industry Trends
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Buyers
5.2.4. Bargaining Power of Suppliers
5.2.5. Intensity of Competitive Rivalry
6. Marijuana Market, By Product Type
7. Marijuana Market, By Application
7.4. Pain Management
7.5. Multiple Sclerosis
8. Marijuana Market, Usage
8.1. Medical Use
8.2. Recreational Use
9. Geographical Analysis
9.2. North America
9.4. Asia Pacific
9.4.1. South Korea
9.5.1. Latin America
9.5.2. Middle East and Africa
10. Company Profiles
(Business Overview, Financial Overview, Product write Up, Recent Developments)
10.1. Canopy Growth Corporation
10.2. GW Pharmaceuticals, PLC
10.3. Medical Marijuana, Inc.
10.4. United Cannabis
10.5. Cannabis Sativa, Inc.
10.6. GreenGro Technologies
10.7. Aurora Cannabis
10.8. CannaGrow Holdings, Inc.
10.9. Cara Therapeutics.
10.10. GBSciences, Inc.
10.11. Lexaria Bioscience Corp.
10.12. Aphria (Liberty Health Sciences)
(Another brief information of 14 companies will be provided in the report.)
11. Competitive Analysis
11.2. Market Positioning of Key Players
11.3 Competitive Strategies Adopted by Leading Players
11.3.1. Investments & Expansions
11.3.2. New Product Launches
11.3.3. Mergers & Acquisitions
11.3.4. Agreements, Joint Ventures, and Partnerships
12.2. Available Customizations
12.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)
No Content Available.